Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant Candida auris

  • Dana Kappel
  • , Hugh Gifford
  • , Amelie Brackin
  • , Alireza Abdolrasouli
  • , David W. Eyre
  • , Katie Jeffery
  • , Silke Schlenz
  • , David M. Aanensen
  • , Colin S. Brown
  • , Andrew Borman
  • , Elizabeth Johnson
  • , Alison Holmes
  • , Darius Armstrong-James
  • , Matthew C. Fisher
  • , Johanna Rhodes*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Candida auris is a globally emerged fungal pathogen causing nosocomial invasive infections. Here, we use cutting-edge genomic approaches to elucidate the temporal and geographic epidemiology of drug-resistant C. auris within the UK. We analysed a representative sample of over 200 isolates from multiple UK hospitals to assess the number and timings of C. auris introductions and infer subsequent patterns of inter- and intra-hospital transmission of azole drug-resistant isolates. We identify at least one introduction from Clade I and two from Clade III into the UK, and observe temporal and geographical evidence for multiple transmission events of antifungal drug resistant isolates between hospitals and identified local within-hospital patient-to-patient transmission events. Our study confirms outbreaks of drug-resistant C. auris are linked and that transmission amongst patients occurs, explaining local hospital outbreaks, and demonstrating a need for improved epidemiological surveillance of C. auris to protect patients and healthcare services.

Original languageEnglish
Article number26
Journalnpj Antimicrobials and Resistance
Volume2
Issue number1
DOIs
Publication statusPublished - 30 Sept 2024

Bibliographical note

© The Author(s) 2024.

Fingerprint

Dive into the research topics of 'Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant Candida auris'. Together they form a unique fingerprint.

Cite this